Skip to main content


Maximising the opportunity presented by biosimilar medicines – A national strategy for Wales

This strategy sets out the steps the NHS and its partners in Wales will take to support the conditions needed to create a strong, competitive biological and biosimilar medicines’ market in the UK benefiting the NHS, patients and the economy of Wales.

Follow AWTTC: